Literature DB >> 8512110

Pulmonary uptake of propofol in cats. Effect of fentanyl and halothane.

I Matot1, C F Neely, R Y Katz, G R Neufeld.   

Abstract

BACKGROUND: Many drugs are removed by the lung. The pulmonary uptake of one drug can be inhibited when a second, highly accumulated drug is administered parenterally or as a chronic oral treatment. The effect of inhalational anesthetics on pulmonary drug uptake has not been extensively studied and may alter pharmacokinetics of intravenously administered drugs.
METHODS: The uptake of propofol by the lung during a single passage through the pulmonary circulation was studied in four groups of anesthetized cats: spontaneously breathing cats (control group, n = 6), cats whose lungs were mechanically ventilated (n = 6), and cats whose lungs were mechanically ventilated and that were anesthetized with 1% (n = 6) or 1.5% (n = 6) halothane. In an additional group, the single-pass pulmonary uptake of propofol was studied in six spontaneously breathing cats pretreated with fentanyl. The amount of propofol taken up by the lung during the first pass was measured from double indicator-dilution outflow curves using indocyanine green (ICG) as the intravascular reference indicator.
RESULTS: The first-pass uptake of propofol (mean +/- SEM) was 61.3 +/- 4.9% and 60 +/- 3.7% of the injected dose in control cats and in cats whose lungs were mechanically ventilated, respectively. Although exposure of the animals to 1% halothane had no significant effect on pulmonary extraction of propofol, the first-pass uptake decreased significantly to 38.8 +/- 6.9% in cats exposed to 1.5% halothane compared with control cats and to cats undergoing mechanical ventilation of the lungs without exposure to halothane. Also, in animals pretreated with fentanyl, propofol uptake was reduced to 40 +/- 5% compared with the control group.
CONCLUSIONS: The results demonstrate a substantial extraction of propofol by the lung that is not affected by mechanical ventilation. Inhibition of propofol uptake by 1.5% halothane and by fentanyl provides a potential mechanism of drug-drug interaction that may interfere with the pharmacokinetic profile of propofol, and may alter the amount of propofol needed to achieve or supplement a given depth of anesthesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512110     DOI: 10.1097/00000542-199306000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.

Authors:  Haruhiko Hiraoka; Koujirou Yamamoto; Soutarou Miyoshi; Toshihiro Morita; Katsunori Nakamura; Yuuji Kadoi; Fumio Kunimoto; Ryuya Horiuchi
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Hematological, morphological, biochemical and hydromineral responses in Rhamdia quelen sedated with propofol.

Authors:  Luciane Tourem Gressler; Fernando Jonas Sutili; Sílvio Teixeira da Costa; Thaylise Vey Parodi; Tanise da Silva Pês; Gessi Koakoski; Leonardo José Gil Barcellos; Bernardo Baldisserotto
Journal:  Fish Physiol Biochem       Date:  2014-10-02       Impact factor: 2.794

Review 3.  Strategies to optimise propofol-opioid anaesthesia.

Authors:  Bart-Jan Lichtenbelt; Martijn Mertens; Jaap Vuyk
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

4.  Two different approaches for pharmacokinetic modeling of exhaled drug concentrations.

Authors:  S Kreuer; A Hauschild; T Fink; J I Baumbach; S Maddula; Th Volk
Journal:  Sci Rep       Date:  2014-06-24       Impact factor: 4.379

5.  Comparison of the anesthetic effects between 5 mg/kg of alfaxalone and 10 mg/kg of propofol administered intravenously in cats.

Authors:  Jun Tamura; Norihiko Oyama; Sho Fukui; Kazuto Yamashita
Journal:  J Vet Med Sci       Date:  2021-01-08       Impact factor: 1.267

6.  Effects of intermittent positive pressure ventilation on cardiopulmonary function in horses anesthetized with total intravenous anesthesia using combination of medetomidine, lidocaine, butorphanol and propofol (MLBP-TIVA).

Authors:  Tomohito Ishizuka; Jun Tamura; Tsukasa Nagaro; Kanako Sudo; Takaharu Itami; Mohammed Ahamed Umar; Kenjirou Miyoshi; Tadashi Sano; Kazuto Yamashita
Journal:  J Vet Med Sci       Date:  2014-09-03       Impact factor: 1.267

Review 7.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.